Subtle structural abnormalities in genotype positive phenotype ‘negative’ patients with pre-clinical hypertrophic cardiomyopathy (HCM): a blinded, controlled cardiovascular magnetic resonance (CMR) study

Subtle structural abnormalities in genotype positive phenotype ‘negative’ patients with pre-clinical hypertrophic cardiomyopathy (HCM): a blinded, controlled cardiovascular magnetic resonance (CMR) study

Bibliographic Details
Main Authors:	Deva Djeven, Gruner Christiane, Care Melanie, Wintersperger Bernd J, Rakowski Harry, Crean Andrew M
Format:	Article
Language:	English
Published:	Elsevier 2012-02-01
Series:	Journal of Cardiovascular Magnetic Resonance

Similar Items

Incremental predictive value of deep crypts in the basal inferoseptum in the setting of hypertrophic cardiomyopathy
by: Deva Djeven P, et al.
Published: (2013-01-01)

Effect of Aficamten on Structure and Function in Patients with Obstructive Hypertrophic Cardiomyopathy: The FOREST-HCM CMR Sub-study
by: Ahmad Masri, MD, et al.
Published: (2024-01-01)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry
by: Neubauer, S, et al.
Published: (2019)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry
by: Neubauer, S, et al.
Published: (2019)

Evaluation of Subtle Left Ventricular Systolic Abnormalities in Adult Patients with Hypertrophic Cardiomyopathy
by: Ranjan Shetty, et al.
Published: (2014-12-01)

Multilevel modelling for decision support in hypertrophic cardiomyopathy in the SMASH-HCM project
by: Alpo Olavi Värri, et al.
Published: (2024-05-01)

METABOLIC ALTERATION IN HYPERTROPHIC CARDIOMYOPATHY (METAL-HCM STUDY): RANDOMISED DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OF PERHEXILINE THERAPY IN PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
by: Abozguia, K, et al.
Published: (2010)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
by: Dawson Dana, et al.
Published: (2009-01-01)

Pro-arrhythmic Electrophysiological Abnormalities in Subclinical and Overt Hypertrophic Cardiomyopathy; Insights from CMR-ECGI
by: George Joy, MD, et al.
Published: (2024-01-01)

HCM-Echo-VAR-Ensemble: Deep Ensemble Fusion to Detect Hypertrophic Cardiomyopathy in Echocardiograms
by: Abdulsalam Almadani, et al.
Published: (2025-01-01)

Global extracellular volume (ECVglobal) in HCM - the "next generation" test for risk in hypertrophic cardiomyopathy?
by: Sado Daniel, et al.
Published: (2013-01-01)

Venous dysfunction in obstructive hypertrophic cardiomyopathies: Results from the “HCM-Vein” pilot study
by: Patricia Réant, et al.
Published: (2023-04-01)

CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation
by: Dinter Dietmar, et al.
Published: (2009-09-01)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
by: Carballo, S, et al.
Published: (2005)

Complement system specifically C5a receptor, inflammation and hypertrophic cardiomyopathy (HCM) in cats
by: Khor, Kuan Hua
Published: (2015)

Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA‐HCM
by: Caroline J. Coats, et al.
Published: (2024-08-01)

Hypertrophic Cardiomyopathy in Elderly Individuals: Is It a Rose by Another Name?
by: Deacon Z. J. Lee, et al.
Published: (2021-02-01)

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death.
by: Dass, S, et al.
Published: (2012)

Developing p21-activated kinase 1 (PAK1) activators to treat hypertrophic cardiomyopathy (HCM)
by: Yu He, et al.
Published: (2024-11-01)

The D‐HCM score, a new diagnostic tool for distinguishing hypertrophic cardiomyopathy from hypertensive cardiopathy
by: G. Domain, et al.
Published: (2024-12-01)

The design and rationale of the cardiac REHABilitation to improve metabolic health in Hypertrophic CardioMyopathy (REHAB-HCM) Study
by: Matthew Cheung, et al.
Published: (2025-02-01)

Further refining risk in hypertrophic cardiomyopathy with late gadolinium enhancement by CMR
by: Kramer, C, et al.
Published: (2018)

The use of multiparametric CMR to predict impaired exercise capacity in hypertrophic cardiomyopathy
by: Pasquale Ferdinando, et al.
Published: (2009-01-01)

Reply: CMR assessment of myocyte disarray in HCM: matching another piece in the puzzle
by: Ariga, R, et al.
Published: (2019)

Role of inflammation in the pathogenesis of hypertrophic cardiomyopathy: a T2-mapping CMR study
by: Ismail Tevfik F, et al.
Published: (2012-02-01)

Assessment of prognostic LV parameters with CMR in hypertrophic cardiomyopathy: impact of the papillary muscles
by: Gommans Frank, et al.
Published: (2012-02-01)

CMR derived MAPSE and TAPSE Measurements in hypertrophic cardiomyopathy: comparison to healthy volunteers
by: Abdel-Aty Hassan, et al.
Published: (2012-02-01)

Delineating the role of adenosine monophosphate (AMP)-activated protein kinase (AMP) gamma 2 subunit in hypertrophic cardiomyopathy (HCM)
by: Grignani, R, et al.
Published: (2005)

Echocardiographic Changes Following Surgical Myectomy in Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy: Insights From the SPIRIT‐HCM Study
by: Milind Y. Desai, et al.
Published: (2025-01-01)

Late gadolinium enhancement (LGE) on Cardiac MR is a powerful predictor of death and “hard” events in patients with hypertrophic cardiomyopathy (HCM)
by: Bhatti Sabha, et al.
Published: (2012-02-01)

Validation of ACC/AHA and ESC Sudden Cardiac Death Risk Guidelines in Diverse Hypertrophic Cardiomyopathy Cohort: Stratification HCM Study
by: Murillo Oliveira Antunes, et al.
Published: (2024-12-01)

Inhibition of miR-199a-3p in a murine hypertrophic cardiomyopathy (HCM) model attenuates fibrotic remodeling
by: Irina Zalivina, et al.
Published: (2023-12-01)

Low diagnostic yield of Late Gadolinium Enhancement (LGE) in screening patients with suspected Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) by Cardiovascular Magnetic Resonance (CMR)
by: van Hoorn Frans, et al.
Published: (2012-02-01)

Hypertrophic Cardiomyopathy Complicated by Pulmonary Edema in the Postpartum Period
by: Kate Hanneman, et al.
Published: (2013-01-01)

Direct mitral regurgitation quantification in hypertrophic cardiomyopathy using 4D flow CMR jet tracking: evaluation in comparison to conventional CMR
by: Aakash N. Gupta, et al.
Published: (2021-12-01)

Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics
by: Lynne K. Williams, et al.
Published: (2017-08-01)

Fluid Characteristics Perturbation in the Aorta of HCM Patients. a CMR Computational Fluid Dynamic Study
by: Abdallah Naser, MD, et al.
Published: (2024-01-01)

Age-dependent hypertrophy and fibrosis dynamics in hypertrophic cardiomyopathy: Insights from longitudinal CMR studies
by: Sebastian M. Haberkorn, et al.
Published: (2024-12-01)

Initial Experience of DT-CMR with Ultra-high-performance Gradient Scanner in Patients with Hypertrophic Cardiomyopathy
by: Shi Chen, BSc, et al.
Published: (2024-01-01)

Left Atrial Strains in Discriminating Phenocopy Diseases FBom Hypertrophic Cardiomyopathy: A CMR Study
by: Xiaorui Xiang, MD, et al.
Published: (2024-01-01)